|
IAC Express 2010 |
| Issue number 865: May 3, 2010 |
|
|
Please click here to subscribe to IAC Express
as well as other FREE IAC periodicals. |
|
Contents
of this Issue
Select a title to jump to the article. |
- Reminder: April 2010 issues of Needle Tips and Vaccinate
Adults available online
- MMWR publishes ACIP's guidance for use of high-dose
inactivated influenza vaccine in people age 65 years and
older
- IAC's Video of the Week is a rebroadcast of PBS's "The
Vaccine War"
- Shingles
vaccine VIS now available in Spanish
- MMWR presents state-by-state statistics on seasonal
influenza vaccination coverage during August 2009-January
2010
- Keep
vaccinating against H1N1 and seasonal influenza!
- VISs for Gardasil and Cervarix human papillomavirus
vaccines now available in four translations
- MMWR corrects some references that appeared in the March
2010 ACIP recommendations for rabies postexposure
prophylaxis
|
| |
| Abbreviations |
|
|
AAFP, American Academy of Family Physicians; AAP,
American Academy of Pediatrics; ACIP, Advisory Committee on Immunization
Practices; AMA, American Medical Association; CDC, Centers for Disease
Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization
Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD,
National Center for Immunization and Respiratory Diseases; NIVS, National
Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD,
vaccine-preventable disease; WHO, World Health Organization. |
| |
|
Issue 865: May 3, 2010 |
|
|
|
1. |
Reminder: April 2010 issues of Needle Tips and Vaccinate Adults available
online
The April 2010 issues of Needle Tips and
Vaccinate Adults
are available online for viewing, downloading, and printing.
Both issues focus on IAC's newly revised summaries of
recommendations for immunization. The content of Vaccinate
Adults is similar to that of Needle Tips, except the
pediatric information has been removed from Vaccinate
Adults.
Complete information about the April 2010 issue of Needle
Tips is available at http://www.immunize.org/nt There you
will find a link for displaying and printing the entire 24-page PDF of the issue, along with a table of contents for
viewing and printing individual sections of Needle Tips.
To download the entire issue of Needle Tips right now, go
to: http://www.immunize.org/nslt.d/n44/n44.pdf
Complete information about the April 2010 issue of Vaccinate
Adults is available at http://www.immunize.org/va
To download the entire issue of Vaccinate Adults right now,
go to: http://www.immunize.org/va/va27.pdf
Back to top |
| |
|
|
2. |
MMWR publishes ACIP's guidance for use of high-dose inactivated influenza
vaccine in people age 65 years and older
CDC published "Licensure of a High-Dose
Inactivated
Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010" in the
April 30 issue of MMWR. A portion of the first paragraph and
the section on guidance for use are reprinted below.
Persons aged >=65 years are at greater risk for
hospitalization and death from seasonal influenza compared
with other age groups, and they respond to vaccination with
lower antibody titers to influenza hemagglutinin (an
established correlate of protection against influenza)
compared with younger adults. On December 23, 2009, the Food
and Drug Administration (FDA) licensed an injectable
inactivated trivalent influenza vaccine (Fluzone High-Dose,
sanofi-pasteur) that contains an increased amount of
influenza virus hemagglutinin antigen compared with other
inactivated influenza vaccines such as Fluzone. Fluzone
High-Dose is licensed as a single dose for use among persons
aged >=65 years and will be available beginning with the
2010-11 influenza season. . . . .
ACIP GUIDANCE FOR USE OF FLUZONE HIGH-DOSE
Fluzone High-Dose may be used for persons aged >=65 years.
All persons aged >=6 months are recommended for annual
influenza vaccination beginning with the 2010-11 influenza
season. ACIP has not expressed a preference for any specific
licensed inactivated trivalent influenza vaccine, including
Fluzone High-Dose, for use in persons aged >=65 years. Data
demonstrating greater protection against influenza illness
after vaccination with Fluzone High-Dose are needed to
evaluate whether Fluzone High-Dose is a more effective
vaccine for persons aged >=65 years. A 3-year postlicensure
study of the vaccine effectiveness of Fluzone High-Dose
compared with standard dose inactivated influenza vaccine
(Fluzone) was begun in 2009 and should be completed in 2012.
As with other inactivated influenza vaccines, Fluzone High-Dose should not be administered to anyone with a known
hypersensitivity to egg proteins or influenza vaccine.
Adverse events after receipt of any vaccine should be
reported to the Vaccine Adverse Event Reporting System at
http://vaers.hhs.gov
To access the MMWR article in PDF format, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5916.pdf and see pages 485-486.
For the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5916a2.htm
Back to top |
| |
|
|
3. |
IAC's Video of the Week is a rebroadcast of PBS's "The Vaccine War"
IAC encourages IAC Express readers to watch the
55-minute
rebroadcast of PBS's Frontline episode "The Vaccine War."
The episode, which aired nationally on April 27, examines
the emotionally charged debate over vaccines that is
increasingly being played out through social media such as
Facebook and Twitter.
The video will be available on the home page of IAC's
website through May 9. To access it, go to: http://www.immunize.org and click on the image under the
words Video of the Week.
Remember to bookmark IAC's home page to view a new video
every Monday. To view an IAC Video of the Week from the
past, go to the video archive at http://www.immunize.org/votw
Back to top |
| |
|
|
4. |
Shingles vaccine VIS now available in Spanish
Dated 10/6/09, the VIS for shingles (zoster)
vaccine is now
available in Spanish. IAC gratefully acknowledges the
California Department of Public Health, Immunization Branch,
for the translation.
To access the Spanish translation of the VIS for shingles,
as well as this VIS in English and other translations, go
to: http://www.immunize.org/vis/vis_shingles.asp
For information about the use of VISs, and for VISs in more
than 35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
| |
|
|
5. |
MMWR presents state-by-state statistics on seasonal influenza vaccination
coverage during August 2009-January 2010
CDC published "Interim Results: State-Specific
Seasonal
Influenza Vaccination Coverage--United States, August 2009-January 2010" in the April 30 issue of MMWR. The first
paragraph is reprinted below.
The advent of the 2009 influenza A (H1N1) pandemic in April
2009 made the 2009-10 influenza season highly unusual.
Public awareness of the potential seriousness of influenza
was heightened by media coverage of pandemic-associated
hospitalizations and deaths, especially among younger
persons. In the fall, the distribution of two separate
influenza vaccines began, with distinct, although
overlapping, recommendations from the Advisory Committee on
Immunization Practices (ACIP). In addition, 2009-10 was the
first full season in which ACIP's recommendation to
vaccinate all children aged 5-18 years was implemented. To
provide preliminary state-specific estimates of seasonal
influenza vaccination coverage, CDC analyzed Behavioral Risk
Factor Surveillance System (BRFSS) and National 2009 H1N1
Flu Survey (NHFS) data collected during October 2009-February 2010. By January 31, estimated state seasonal
influenza vaccination coverage among persons aged >=6 months
ranged from 30.3% to 54.5% (median: 40.6%). Median coverage
was 41.2% for children aged 6 months-17 years, 38.3% for
adults aged 18-49 years with high-risk conditions, 28.8% for
adults aged 18-49 years without high-risk conditions, 45.5%
for adults aged 50-64 years, and 69.3% for adults aged >=65
years. These results, compared with the previous season,
suggest large increases in coverage for children and a
moderate increase for adults aged 18-49 years without high-risk conditions. Health departments should identify best
practices that led to higher vaccination coverage and should
support effective vaccination services (e.g., school-located
vaccination programs and office-based protocols, such as
reminder/recall and standing orders).
For the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5916a1.htm
Back to top |
| |
|
|
6. |
Keep vaccinating against H1N1 and seasonal influenza!
Please continue to vaccinate patients against
H1N1 and
seasonal influenza (as vaccine supplies permit). Remember:
2009 H1N1 influenza vaccine will not protect people against
seasonal influenza, and seasonal influenza vaccine will not
protect against H1N1 influenza.
Providers who don't have H1N1 vaccine or seasonal influenza
vaccine can direct patients to the Google Flu Shot Finder at
http://www.google.com/flushot
Back to top |
| |
|
|
7. |
VISs for Gardasil and Cervarix human papillomavirus vaccines now available in
four translations
Dated 3/30/10, the VISs for Gardasil and Cervarix
human
papillomavirus (HPV) vaccines are now available in Armenian,
Cambodian, Farsi (spoken in Bahrain, United Arab Emirates,
and Iran), and Tagalog. IAC gratefully acknowledges the
California Department of Public Health, Immunization Branch,
for the translations.
To access the new translations of the Gardasil VIS, as well
as this VIS in English and other translations, go to:
http://www.immunize.org/vis/vis_hpv_gardasil.asp
To access the new translations of the Cervarix VIS, as well
as this VIS in English and other translations, go to:
http://www.immunize.org/vis/vis_hpv_cervarix.asp
For information about the use of VISs, and for VISs in more
than 35 languages, visit IAC's VIS web section at
http://www.immunize.org/vis
Back to top |
| |
|
|
8. |
MMWR
corrects some references that appeared in the March 2010 ACIP recommendations
for rabies postexposure prophylaxis
CDC published Errata: "Vol.59, No.RR-2" in the
April 30
issue of MMWR. A portion of the first paragraph is reprinted
below.
In "Use of a Reduced (4-Dose) Vaccine Schedule for
Postexposure Prophylaxis to Prevent Human Rabies:
Recommendations of the Advisory Committee on
Immunization Practices," errors occurred in the references
on page 8. . . .
[IAC Express editor's note: To access text about the
corrected references, click on the link below.]
For the full article in web-text (HTML) format, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5916a5.htm
Back to top |
|
